93
Participants
Start Date
September 30, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
January 31, 2012
AZD8848
Nasal spray solution, intranasal, three times weekly for one month
Placebo
Nasal spray solution, intranasal, three times weekly for one month
AZD8848 and placebo
Nasal spray solution, intranasal, three times weekly for one month
Research Site, Lund
Research Site, Helsingborg
Lead Sponsor
AstraZeneca
INDUSTRY